Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-11-08
2005-11-08
Chan, Christina (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S326000
Reexamination Certificate
active
06962974
ABSTRACT:
Proteins with anti-angiogenic properties are disclosed, and fragments thereof, and methods of using those proteins and fragments to inhibit or promote angiogenesis.
REFERENCES:
patent: 5114840 (1992-05-01), Tryggvason et al.
patent: 5424408 (1995-06-01), Reeders et al.
patent: 5567609 (1996-10-01), Sarras, Jr. et al.
patent: 5593900 (1997-01-01), Tryggvason et al.
patent: 5691182 (1997-11-01), Sarras, Jr. et al.
patent: 5731192 (1998-03-01), Reeders et al.
patent: 5753230 (1998-05-01), Brooks et al.
patent: 5766591 (1998-06-01), Brooks et al.
patent: 5856184 (1999-01-01), Sarras, Jr. et al.
patent: 5973120 (1999-10-01), Reeders et al.
patent: 6007980 (1999-12-01), Reeders et al.
patent: 6017926 (2000-01-01), Askew et al.
patent: WO 89/03392 (1989-04-01), None
patent: WO 91/08755 (1991-06-01), None
patent: WO 91/09113 (1991-06-01), None
patent: WO 96/00582 (1996-01-01), None
patent: WO 97/06791 (1997-02-01), None
patent: WO 97/45137 (1997-12-01), None
patent: WO 99/02551 (1999-01-01), None
patent: WO 99/16465 (1999-04-01), None
patent: WO 99/49885 (1999-10-01), None
patent: WO 99/65940 (1999-12-01), None
patent: WO 00/11475 (2000-03-01), None
patent: WO 00/31248 (2000-03-01), None
patent: WO 00/59532 (2000-03-01), None
Maeshima Y, et al. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol. Chem. 276(34):31959-68, 2001.
Colorado, P.C. et al., 1999, “Arresten: Angiogenesis and Renal Cell Carcinoma Tumor Inhibiting Matrix Protein”,J. Amer. Soc. Nephrol.10:489A.
Colorado, P.C. et al., 2000, “Anti-Angiogenic Cues From Vascular Basement Membrane Collagen”,Cancer Res.60:2520-2526.
Kalluri, R. and V.P. Sukhatme, “Fibrosis and Angiogenesis”,Curr. Opin. Nephrol. Hypert.9:413-418 (2000).
Kamphaus, G.D. et al., 1999, “Canstatin: A Novel Matrix Derived Inhibitor of Angiogenesis and Renal Cell Carcinoma Tumor Growth”,J. Amer. Soc. Nephrol.10:495A.
Kefalides, N.A. et al., 1999, “Suppression of Tumor Cell Growth By Type IV Collagen and a Peptide From the NC1 Domain of the α3 (IV) Chain”,Medicina59:553.
Maeshima, Y. et al., 2000, “Two RGD-Independent ανβ3Integrin Binding Sites on Tumstatin Regulate Distinct Anti-Tumor Properties”,J. Biol. Chem.275:23745-23750.
Maeshima, Y. et al., “Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane”,J. Biol. Chem.275:21340-21348 (2000).
Nickols, A. et al., 1997, “Antiangiogenic and anticancer Activities of Antagonists if Integrin α84β3”,Proc. Ann. Mtg. Amer. Assoc. Cancer Res.38:206.
Varner, J.A., 1997, “The Role of Vascular Cell Integrins ανβ3and ανβ5in Angiogenesis”,Regulation of Angiogenesis,Biurkhauser Verlag, Basel, Switzerland, pp. 361-390.
Butkowski, R.J., et al., “Properties of the Globular Domain of Type IV Collagen and Its Relationship to the Goodpasture Antigen,”The Journal of Biological Chemistry,260(6):3739-3747 (Mar. 25, 1985).
Gunwar, S., et al., “Properties of the Collagenous Domain of the α3 (IV) Chain, the Goodpasture Antigen, of Lens Basement Membrane Collagen,”The Journal of Biological Chemistry,266(21):14088-14094 (Jul. 25, 1991).
Gunwar, S., et al., “Glomerular Basement Membrane,”The Journal of Biological Chemistry,273(15):8767-8775 (Apr. 10, 1998).
Hostikka, S.L. and Tryggvason, K., “The Complete Primary Structure of the α2 Chain of Human Type IV Collagen and Comparison with the α1 (IV) Chain,”The Journal of Biological Chemistry,263(36):19488-19493 (Dec. 25, 1988).
Kalluri, R., et al., “The α3 chain of type IV collagen induces autoimmune Goodpasture syndrome,”Proc. Natl. Acad. Sci. USA,91:6201-6205 (Jun. 1994).
Kalluri, R. et al., “The Goodpasture Autoantigen,”The Journal of Biological Chemistry,271(15):9062-9068 (Apr. 12, 1996).
Kalluri, R., et al., “Isoform Switching of Type IV Collagen is Developmentally Arrested in X-Linked Alport Syndrome Leading to Increased Susceptibility of Renal Basement Membranes to Endoproteolysis,”J. Clin. Invest.,99(10) :2470-2478 (May 1997).
Langeveld, J.P.M., et al., “Structural Heterogeneity of the Noncollagenous Domain of Basement Membrane Collagen,”The Journal of Biological Chemistry,263(21):10481-10488 (Jul. 25, 1988).
Liotta, L.A., “Cancer Cell Invasion and Metastasis,”Scientific American,54-64 (Feb. 1992).
Maragoudakis, M.E., et al., “Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties,”Kidney International,43:147-150 (1993).
Mariyama, M., et al., “The α4 (IV) Chain of Basement Membrane Collagen,”The Journal of Biological Chemistry,267(2):1253-1258 (Jan. 15, 1992).
Mariyama, M., et al., “Colocalization of the Genes for the α3 (IV) and α4 (IV) Chains of Type IV Collagen to Chromosome 2 Bands q35-q37,”Genomics,13:809-813 (1992).
Monboisse, J.C., et al., “The α3 Chain of Type IV Collagen Prevents Activation of Human Polymorphonuclear Leukocytes,”The Journal of Biological Chemistry,269(41):25475-25482 (Oct. 14, 1994).
Morrison, K.E., et al., “Sequence and Localization of a Partial cDNA Encoding the Human α3 Chain of Type IV Collagen,”Am. J. Hum. Genet.,49:545-554 (1991).
Neilson, E.G., et al., “Specificity of Goodpasture Autoantibodies for the Recombinant Noncollagenous Domains of Human Type IV Collagen,”The Journal of Biological Chemistry,268(12):8402-8405 (Apr. 25, 1993).
Prockop, D.J. and Kivirikko, K.I., “COLLAGENS: Molecular Biology, Diseases, and Potentials for Therapy,”Annu. Rev. Biochem.,64:403-34 (1995).
Sarras, Jr., M.P., et al., “Extracellular Matrix (Mesoglea) of Hydra vulgaris,”Developmental Biology,148:481-494 (1991).
Saus, J., et al., “Identification of the Goodpasture Antigen as the α3 (IV) Chain of Collagen IV,”The Journal of Biological Chemistry,283(26):13374-13380 (Sep. 1988).
Timpl, R., et al., “A Network Model for the Organization of Type IV Collagen Molecules in Basement Membranes,”Eur. J. Biochem.,120:203-211 (1981).
Vuorio, E. and de Crombrugghe, B., “The Family of Collagen Genes,”Annu. Rev. Biochem.,59:837-72 (1990).
Zhou, J., et al., “Deletion of the Paired α5(IV) and α6(IV) Collagen Genes in Inherited Smooth Muscle Tumors,”Science,261:1167-1169 (Aug. 27, 1993).
Senger, D.R. et al., “Angiogenesis promoted by vascular endothelial growth factor: Regulation through α1β1and α2β1integrins,”Proc. Natl. Acad. Sci. USA94:13612-13617 (1997).
Prestayko, A.W., et al., “Type IV collagen domains inhibit adhesion and migration of tumor cells and block angiogenesis,”Proceedings of the American Association for Cancer Research,39:45 (Mar. 1998).
Sado, Y., et al., “Induction of anti-GBM nephritis in rats by recombinant α3 (IV)NC1 and α4 (IV)NC1 of type IV collagen,”Kidney International,53:664-671 (1998).
Brinker, J.M., et al., GenBank Acc. No. M11315, Nov. 1, 1994.
Killen, P.D., et al., GenBank Acc. No. M24766, Nov. 1, 1994.
Quinones, S., et al., GenBank Acc. No. M92993, Sep. 23, 1994.
Turner, N., et al., GenBank Acc. No. M81379, Oct. 30, 1994.
Mariyama, M., et al., GenBank Acc. No. X80031, Oct. 5, 1998.
Han, J., et al., “A Cell Binding Domain from the α3 Chain of Type IV Collagen Inhibits Proliferation of Melanoma Cells,”The Journal of Biological Chemistry,272(33):20395-20401 (1997).
Shahan, T.A., et al., “Identification of CD47/Integrin-associated Protein and ανβ3 as Two Receptors for the α3 (IV) Chain of Type IV Collagen on Tumor Cells,”Cancer Research,59:4584-4590 (1999).
Boudreau, N., et al., “Suppression of ICE and Apoptosis in Mammary Epithelial C
Beth Israel Deaconess Medical Center
Chan Christina
Gyure Barbara A.
Haddad Maher
Palmer & Dodge LLP
LandOfFree
Anti-angiogenic proteins and fragments and methods of use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-angiogenic proteins and fragments and methods of use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-angiogenic proteins and fragments and methods of use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512050